ArticleCureus2026
Multidisciplinary Management of Paediatric Nasolacrimal Duct Obstruction at a Tertiary Hospital: A Five-Year Review.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Nasolacrimal duct obstruction (NLDO) is the most common cause of childhood epiphora. Congenital NLDO is usually managed conservatively in the first year of life; failing which, surgical interventions - such as syringing and probing (S&P), insertion of stents (intubation), or dacryocystorhinostomy (DCR) - are offered in a stepwise manner. The aim of this study was to evaluate the outcomes of our joint ophthalmology-ENT service in the management of NLDO. Methods This was a retrospective study conducted at a tertiary paediatric hospital. Nasolacrimal surgeries were retrieved from Hospital Episode Statistics (HES) data for a five-year period between May 2017 and April 2022. A retrospective case-note review was undertaken to examine demographics, presentation, surgical interventions, and outcomes (classified as complete resolution, partial improvement, or no improvement). Results At our institution, NLDO surgeries are performed on a joint ophthalmology/ENT list. A total of 301 procedures were performed on 218 patients (293 eyes). The causes of epiphora included congenital NLDO (n = 193, 88.5%), secondary NLDO (n = 10, 4.6%), and dacryocystitis/mucocele (n = 8, 3.7%), among others. The median age at the first procedure was 26 months (range: 2-189). The median number of procedures for congenital NLDO was one (range: 1-5). The success rates were 73% for all S&P procedures (n = 135/185), 78% for intubation (n = 76/98), and 58% for DCR (n = 10/17). Patients with craniofacial syndromes required a statistically significantly higher number of DCRs. Overall, epiphora was completely resolved in 81% of cases (n = 237), partially resolved in 6% (n = 18), and was persistent in 13% (n = 38). Conclusion A multidisciplinary approach to NLDO ensures the efficient delivery of care by minimising the number of procedures and hospital attendances. Congenital NLDO can be successfully treated in the vast majority of cases with S&P and intubation. In cases with bony anatomical abnormalities, there should be a low threshold for considering DCR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.